SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-030995
Filing Date
2018-12-17
Accepted
2018-12-17 16:36:05
Documents
3
Period of Report
2018-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-8k_20181213.htm 8-K 39025
2 EX-99.1 phas-ex991_6.htm EX-99.1 10769
3 GRAPHIC gm0q254crt2r000001.jpg GRAPHIC 710846
  Complete submission text file 0001564590-18-030995.txt   1030540
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 181238499
SIC: 2834 Pharmaceutical Preparations